STAAR Surgical Co Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
STAAR Surgical Co (STAA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.80% for the 12-month period ending 2024-12-27, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-03
- STAAR Surgical Co effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -1.80%, a 550.00% decline from fiscal 2023.
- STAAR Surgical Co effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 0.40%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-27 | -1.80% 10-K · filed 2026-03-03 |
| 2023-12-29 | 0.40% 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |